Management of hepatitis C virus infection in liver transplantation with adacolumn apheresis

Transplantation Proceedings

Volumn 44, Issue 7, 2012, Pages 1946-1952

  Novelli, G ^a   Rossi, M ^a   Morabito, V ^a   Ferretti, G ^a   Pretagostini, R ^a   Ruberto, F ^a   Pugliese, F ^a   Guglielmo, N ^a   Berloco, P B ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADACOLUMN APHERESIS; ADULT; CD4 CD8 RATIO; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GRANULOCYTE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKAPHERESIS; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; RECURRENT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK REDUCTION; SURGICAL PATIENT; TREATMENT RESPONSE; VIRUS LOAD; VIRUS REPLICATION;

HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; VIRUS REPLICATION;

EID: 84866315672     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.06.040     Document Type: Conference Paper

References (40)

1. M. Prieto, M. Berenguer, J.M. Rayon High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes Hepatology 29 1999 250
2. L.M. Forman, J.D. Lewis, J.A. Berlin, H.I. Feldman, M.R. Lucey The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889
3. J. Dumortier, J.Y. Scoazec, P. Chevallier Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination J Hepatol 40 2004 669
4. M. Berenguer, A. Palau, V. Aguilera Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation Am J Transplant 8 2008 679
5. D. Samuel, T. Bizollon, C. Feray Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study Gastroenterology 124 2003 642
6. J.A. Carrion, M. Navasa, M. Garcia-Retortillo Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study Gastroenterology 132 2007 1746
7. H. Rodriguez-Luna, H.E. Vargas Management of hepatitis C virus infection in the setting of liver transplantation Liver Transpl 11 2005 479
8. M. Garcia-Retortillo, X. Forns, A. Feliu Hepatitis C virus kinetics during and immediately after liver transplantation Hepatology 35 2002 680
9. M. Cravatto, G. Pozzato, F. Zorat Peripheral blood neutrophils from hepatitis C virus-infected patients are replication sites for the virus Haematologica 85 2000 356
10. C. Caussin-Scwemling, C. Scmitt, F. Stoll-Keller Study of the infection of human blood derived monocyte/macrophage with hepatitis C virus in vitro J Med Virol 65 2001 14
11. P. Bouffard, P.H. Hayashi, R. Acevedo Hepatitis C is detected in a monocyte macrophage subpopulation of peripheral blood mononuclear cells of infected patients J Infect Dis 166 1992 1276
12. M. Ohara, A.R. Saniabadi, I. Hirata Granulocytapheresis in the treatment of patients with rheumatoid arthritis Artif Organs 21 1997 989
13. C.R. Yu, R.M. Mahdi, S. Ebong Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells J Biol Chem 278 2003 29752
14. T.E. Hugli Structure and functions of anaphylotoxins Springer Semin Immunopathol 7 1984 193
15. W. Vogt Drugs and the complement system Trends Pharmacol Sci 6 1985 114
16. C. D'Arrigo, J.J. Candal-Couto, M. Greer Human neutrophil Fc receptor-mediated adhesion under flow: a hollow fiber model of intravascular arrest Clin Exp Immunol 100 1993 173
17. G.D. Ross, M.E. Medof Membrane complement receptors specific for bound fragments of C3 Adv Immunol 37 1985 217
18. R.G. Worth, L. Mayo-Bond, J.G. van de Winkel CR3 (alphaM beta2; CD11b/CD18) restores IgG-dependent phagocytosis in transfectants expressing a phagocytosis-defective Fc gammaRIIA (CD32) tail-minus mutant J Immunol 157 1996 5660
19. R.S. Brown Hepatitis C and liver transplantation Nature 436 2005 973
20. R.H. Wiesner, M. Sorrell, F. Villamil International Liver Transplantation Society Expert Panel Report of the first international liver transplantation society expert panel consensus conference on liver transplantation and hepatitis C Liver Transpl 9 2003 S1
21. J.S. Crippin, T. McCashland, N. Terrault A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation Liver Transpl 8 2002 350
22. A.O. Shakil, B. McGuire, J. Crippin A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C Hepatology 36 2002 1253
23. T.D. Schiano, P. Martin Management of HCV infection and liver transplantation Int J Med Sci 3 2006 79
24. A.R. Saniabadi, H. Hanai, K. Takeuchi Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes Ther Apher Dial 7 2003 48
25. T. Maniere, C. Ethier, V.A. Raymond Cyclosporine reduces hepatitis C virus replication in the replicon model J Hepatol 40 suppl 2004 S120
26. Y. Suzuki, N. Yoshimura, A.R. Saniabadi, Y. Saito Selective granulocyte and monocyte adsorptive apheresis as a first line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study Dig Dis Sci 49 2004 565
27. A. Grakoui, N.H. Shoukry, D.J. Woollard HCV persistence and immune evasion in the absence of memory T cell help Science 302 2003 659
28. K.M. Chang Immunopathogenesis of hepatitis C virus infection Clin Liver Dis 7 2003 89
29. J. Sreenarasimhaiah, A. Jaramillo, J. Crippin Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection Hum Immunol 64 2003 497
30. H2) in chronic hepatitis C patients with a sustained response or no response to IFN Hepatol Res 27 2003 260
31. R.K. Gershon A disquisition on suppressor T cells Transplant Rev 26 1975 170
32. S. Sakaguchi, N. Sakaguchi, J. Shimizu Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunol Rev 182 2001 18
33. S. Sakaguchi, N. Sakaguchi, J. Shimizu What is the role of regulatory T cells in transplantation? Curr Opin Immunol 11 1999 497
34. Y. Zhai, J.W. Kupiec-Weglinski Immunologic tolerance maintained by activated T cells expressing 11.2 receptor-chains (CD25) J Immunol 155 1995 1151
35. N. Kashiwagi, I. Hirata, R. Kasukawa A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis Ther Apher 2 1998 134
36. H. Hanai, F. Watanabe, A. Saniabadi Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis Dig Dis Sci 47 2002 2349
37. S. Ilangumaran, R. Rottapel Regulation of cytokine receptor signaling by SOCS1 Immunol Rev 192 2003 196
38. A.L. Cornish, M.M. Chong, G.M. Davey Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells J Biol Chem 278 2003 22755
39. C.R. Yu, R.M. Mahdi, S. Ebong, B.P. Vistica, I. Gery, C.E. Egwuagu Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells J Biol Chem 278 2003 29752
40. M.M. Song, K. Shuai The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferonmediated antiviral and antiproliferative activities J Biol Chem 273 1998 35056